Markets:

Overview

News

Currencies

International

Treasuries

Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares (NQ:KNSA)

46.37 -0.93 (-1.97%)

Streaming Delayed Price Updated: 1:47 PM EDT, Apr 14, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares

< Previous 1 2 3 4 5 Next >

5 Value Stocks To Watch In The Healthcare Sector ↗

August 21, 2023

Via Benzinga

Vertex Pharmaceuticals Stock Shows Rising Relative Strength, Hits 80+ ↗

August 16, 2023

Vertex Pharmaceuticals shows improving price performance, earning an upgrade to its IBD Relative Strength Rating from 78 to 81.

Via Investor's Business Daily

ACELYRIN Stock Scores Relative Strength Rating Upgrade; Hits Key Threshold ↗

August 15, 2023

One key metric to look for in a stock is an 80-plus Relative Strength Rating. ACELYRIN stock hit that mark on Tuesday, with a jump to 81.

Via Investor's Business Daily

Axsome Therapeutics Stock Earns Relative Strength Rating Upgrade ↗

August 15, 2023

A Relative Strength Rating upgrade for Axsome Therapeutics shows improving technical performance.

Via Investor's Business Daily

Exelixis Stock Sees Rising Relative Strength Rating ↗

August 14, 2023

On Monday, Exelixis stock hit an key technical milestone, with its Relative Strength Rating rising to 87, an increase from 79 the day before.

Via Investor's Business Daily

Dynavax Technologies Stock Sees Renewed Technical Strength ↗

August 07, 2023

Dynavax Technologies shows rising price performance, earning an upgrade to its IBD Relative Strength Rating from 79 to 84.

Via Investor's Business Daily

Why Shares of Kiniksa Pharmaceuticals Jumped Tuesday ↗

July 25, 2023

The company reported a big jump in revenue and updated guidance.

Via The Motley Fool

Kiniksa Pharmaceuticals Ltd. (NASDAQ: KNSA) Near the Top of Equities by Percentage Gain on 7/25

July 25, 2023

Via Investor Brand Network

Earnings Outlook For Kiniksa Pharmaceuticals ↗

July 24, 2023

Via Benzinga

Crude Oil Up 1%; Verizon Earnings Beat Views ↗

July 25, 2023

U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining more than 100 points on Tuesday. The Dow traded up 0.28% to 35,510.96 while the NASDAQ rose 0.91% to 14,187.05....

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

July 25, 2023

Via Benzinga

Why Alaska Air Group Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

July 25, 2023

Gainers Aurora Acquisition Corp. (NASDAQ: AURC) shares jumped 192% to $30.54.

Via Benzinga

Overview Of Value Stocks In The Healthcare Sector ↗

June 05, 2023

Via Benzinga

Xerox, Logitech International, Packaging Corporation of America And Other Big Stocks Moving Higher On Tuesday ↗

July 25, 2023

U.S. stocks traded higher, with the Nasdaq Composite gaining around 75 points on Tuesday. Here are some big stocks recording gains in today’s session. Kiniksa Pharmaceuticals, Ltd. (NASDAQ: KNSA)...

Via Benzinga

5 Value Stocks In The Healthcare Sector ↗

July 24, 2023

Via Benzinga

3 Small-Cap Stocks That Are Worth the Gamble ↗

July 04, 2023

Although these small-cap stock picks may not be household names, they command significant upside potential for daring speculators.

Via InvestorPlace

Abcam Stock Earns Relative Strength Rating Upgrade ↗

June 20, 2023

A Relative Strength Rating upgrade for Abcam ADR shows improving technical performance.

Via Investor's Business Daily

FibroGen Stock Joins Rank Of Stocks With RS Ratings Over 90 ↗

June 06, 2023

On Tuesday, FibroGen stock saw a positive improvement to its Relative Strength Rating, rising to 94 from 90 a day earlier.

Via Investor's Business Daily

A Look Into Healthcare Sector Value Stocks ↗

May 22, 2023

Via Benzinga

5 Value Stocks In The Healthcare Sector ↗

January 09, 2023

Via Benzinga

Kiniksa Inks Global License Agreement With Roche For Vixarelimab ↗

August 03, 2022

Via Benzinga

7 Thrilling Biotech Stocks for Aggressive Investors to Buy ↗

April 05, 2023

Amid the noise of the global markets recently, these speculative biotech stocks to buy might trade with a mind of their own.

Via InvestorPlace

7 Small-Cap Stocks to Buy for Explosive Growth Potential ↗

March 30, 2023

Although small-cap stocks to buy presents higher risks than the large caps, the segment also enjoys critical advantages.

Via InvestorPlace

7 Dirt-Cheap Stocks Sitting in the Sweet Spot ↗

March 23, 2023

These cheap stocks don’t just attract on the ticker tape but rather feature compelling fundamentals and analysts’ upside projections.

Via InvestorPlace

The Top 7 Growth Stocks in Biotech ↗

March 03, 2023

The biotech sector always houses a great selection of growth stocks that can grow rapidly and reward investors over the long-term.

Via InvestorPlace

Gartner, Sony, Uber And Other Big Gainers From Tuesday ↗

November 02, 2022

U.S. stocks closed lower on Tuesday, with the Nasdaq Composite dropping around 100 points. Here is the list of some big stocks recording gains in the previous session.

Via Benzinga

Why Harsco Shares Surged Over 22%; Here Are 80 Biggest Movers From Yesterday ↗

November 02, 2022

Gainers

Via Benzinga

Why Abiomed Shares Are Trading Higher By Over 50%? Here Are 60 Stocks Moving In Tuesday's Mid-Day Session ↗

November 01, 2022

Gainers Safe-T Group Ltd (NASDAQ: SFET) shares surged 63.7% to $0.4910 as the company said its privacy application reached over 5,000,000 downloads.

Via Benzinga

Recap: Kiniksa Pharmaceuticals Q3 Earnings ↗

November 01, 2022

Kiniksa Pharmaceuticals (NASDAQ:KNSA) reported its Q3 earnings results on Tuesday, November 1, 2022 at 08:00 AM. Here's what investors need to know about the announcement. Earnings Kiniksa...

Via Benzinga

10 Health Care Stocks Whale Activity In Today's Session ↗

October 24, 2022

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...

Via Benzinga

< Previous 1 2 3 4 5 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.